ABCA7 and Alzheimer disease: Examination of methylation and blood gene expression of the ABCA7 gene as a biomarker of AD shows that ABCA7 mRNA expression is higher in AD patients than in healthy controls; in patients with AD, high ABCA7 transcript levels are linked to disease progression and a decline in cognitive function [63].